| Product Name | MF | CAS | Details |
|---|
| 3-(2-Aminophenoxy)propanamide | C9H12N2O2 | 1094235-02-5 | Details |
| Ginsenoyne K | C17H24O3 | 141947-42-4 | Details |
| H-DLLDTASALYR^-OH | Details |
| 5-Ethyl-2-(1H-pyrrol-1-yl)-1,3-thiazole-4-carboxylic acid | C10H10N2O2S | 1623083-99-7 | Details |
| 3-Amino-N-(2-hydroxyethyl)propanamide hydrochloride | C5H13ClN2O2 | 1220037-08-0 | Details |
| AK2 Blocking Peptide | Details |
| (3-Dimethylamino)-1-propylamine | C5H14N2 | 109-55-7 | Details |
| 2a,3b,19a-trihydroxyurs-12-en-28-oic acid 28-b-D-glucopyranosyl ester | Details |
| tert-Butyl N-[1-(1,3,4-oxadiazol-2-yl)ethyl]carbamate | C9H15N3O3 | 1219838-72-8 | Details |
| 1,3-bis(3-methylphenyl)-5-((3,4,5-trimethoxyphenyl)methylene)-1,3-diazaperhydroine-2,4,6-trione | C28H26N2O6 | 1023829-78-8 | Details |
| L-745,870 Trihydrochloride | C18H20Cl2N4 | 866021-03-6 | Details |
| Sodium Dodecylbenzenesulfonate (soft type) (mixture) | C18H29NaO3S | 69669-44-9 | Details |
| 2,4,6-Triethyl-1,3,5-trioxane | C9H18O3 | 2396-42-1 | Details |
| Pseudoginsenoside RT5 | C36H62O10 | 98474-78-3 | Details |
| HER-2/neu 689-697 (HLA-A*02:01) | Details |
| (3S)-3-(Methoxymethyl)morpholine hydrochloride | C6H14ClNO2 | 218594-76-4 | Details |
| Netilmicin sulfate | C42H92N10O34S5 | 56391-57-2 | Details |
| 1-[({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)methyl]-3-methyl-2-oxabicyclo[2.1.1]hexane-4-carboxylic acid | C23H23NO5 | 2228578-51-4 | Details |
| Kynurenic acid | C10H7NO3 | 492-27-3 | Details |
| IL5 antibody | Details |
| N-Boc-hex-5-ynylamine | C11H19NO2 | 151978-58-4 | Details |
| 5-chloro-[1,2,4]triazolo[1,5-a]pyridine | C6H4ClN3 | 1427399-34-5 | Details |
| [1-(4-Fluorophenyl)-3-methyl-1H-pyrazol-4-yl]methanamine hydrochloride | C11H13ClFN3 | 1221724-28-2 | Details |
| EVI1 antibody | Details |
| H-ERFALNPGL-OH | Details |
| Alaptide | C9H14N2O2 | 90058-29-0 | Details |
| H-KTAVQMAVF-OH | Details |
| tert-Butyl 1-(piperidin-4-yl)-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazole-5-carboxylate | C15H24N4O2 | 1909305-30-1 | Details |
| 5-Bromo-3-methylbenzene-1,2-diol | C7H7BrO2 | 1779857-21-4 | Details |
| 2-Amino-2-(3,4-dimethoxyphenyl)propanoic acid | C11H15NO4 | 4454-13-1 | Details |
| 2-Chloro-N-(2-(phenylcarbonyl)phenyl)propanamide | C16H14ClNO2 | 730950-05-7 | Details |
| C2orf60 Blocking Peptide | Details |
| (-)-Epicatechin | C15H14O6 | 490-46-0 | Details |
| NUDT18 Blocking Peptide | Details |
| 5-Hydroxy-1,7-bis(4-hydroxyphenyl)heptan-3-yl acetate | C21H26O5 | 1269839-24-8 | Details |
| Methyl 4-[(propan-2-yl)amino]benzoate | C11H15NO2 | 383185-68-0 | Details |
| 6-Amino-6-deoxy-1,2-O-isopropylidene-a-D-glucofuranose HCl | C9H18ClNO5 | 24384-88-1 | Details |
| Methyl 4-(4-methyl-1,3-thiazol-5-yl)-1H-pyrrole-3-carboxylate | C10H10N2O2S | 1803582-35-5 | Details |
| 3-Chloro-4-fluoro-N-(2-methylpropyl)aniline | C10H13ClFN | 1038734-58-5 | Details |
| H-HTTDPSFLGRY-OH | Details |
| 3-Amino-3-(thiophen-2-yl)propan-1-ol | C7H11NOS | 683220-39-5 | Details |
| 2-amino-5-oxo-7-phenyl-4-(2-thienyl)-4,6,7,8-tetrahydro2H-chromene-3-carbonitrile | C20H16N2O2S | 311326-51-9 | Details |
| 2-?[(Tetrahydro-?1,?1-?dioxido-?3-?thienyl)?oxy]?-ethanamine | C6H13NO3S | 857626-00-7 | Details |
| 3-Iodo-2-methyl-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine hydrochloride | 2138044-43-4 | Details |
| 6-Methoxy-4-methyl-1H,2H,3H,4H-pyrido[2,3-b]pyrazine | C9H13N3O | 1314922-89-8 | Details |
| (2E)-3-(2-Chloro-3-fluorophenyl)prop-2-enoic acid | C9H6ClFO2 | 1214791-04-4 | Details |
| Bpo-27 racemate | C26H18BrN3O6 | 1314873-02-3 | Details |
| Hexokinase 2 antibody (N-terminus) | Details |
| Imazalil sulfate | C14H14Cl2N2O.H2O4S | 58594-72-2 | Details |
| 4-[(3-Hydroxypropyl)sulfanyl]benzoic acid | C10H12O3S | 254910-61-7 | Details |
| Acremine I | C12H16O5 | 1110661-29-4 | Details |
| {Bicyclo[3.2.0]heptan-6-yl}methanamine hydrochloride | 2155855-26-6 | Details |
| Queuine hydrochloride | C12H15N5O3 | 72496-59-4 | Details |
| 1-Benzothiophene-5-sulfonyl chloride | C8H5ClO2S2 | 128852-05-1 | Details |
| 4-(3-Bromophenyl)-4-methyl-1,3-oxazolidin-2-one | C10H10BrNO2 | 1479298-59-3 | Details |
| 4-Bromo-5,6,7,8-tetrahydroquinoline | C9H10BrN | 881204-70-2 | Details |
| N-Methyl-2-nitropyridin-3-amine | C6H7N3O2 | 32605-06-4 | Details |
| (+/-)-SeDMA | Details |
| tert-butyl 1-oxa-4,8-diazaspiro[5.5]undecane-4-carboxylate | C13H24N2O3 | 1160247-06-2 | Details |
| 2'-Deoxycytidine-3'-monophosphate ammonium salt | C9H17N4O7P | 102783-50-6 | Details |
| 4-[(4H-1,2,4-Triazol-3-ylsulfanyl)methyl]benzoic acid hydrochloride | C10H10ClN3O2S | 1258650-03-1 | Details |
| N-[4-(cyanomethyl)phenyl]-1-phenylcyclopentane-1-carboxamide | C20H20N2O | 591241-84-8 | Details |
| 1-Bromo-2,4-dimethylhexane | C8H17Br | 13285-68-2 | Details |
| Methyl 2-[4-(1H-1,2,3,4-tetrazol-1-yl)phenyl]acetate | C10H10N4O2 | 1803605-61-9 | Details |
| Ethyl 4-(4-chlorophenyl)-2,4-dioxobutanoate | C12H11ClO4 | 5814-38-0 | Details |
| 8-[(9H-Fluoren-9-ylmethoxy)carbonyl]-1-oxa-2,8-diazaspiro[4.5]dec-2-ene-3-carboxylic acid | C23H22N2O5 | 1803562-58-4 | Details |
| Mouse Thrombocyte antibody | Details |
| 5-Methyl-1-(pyridin-2-yl)-1H-pyrazole-3-carboxylic acid | C10H9N3O2 | 340720-08-3 | Details |
| 4-Cyclopentylpyrrolidin-2-one | C9H15NO | 271580-00-8 | Details |
| N-(4-Chlorophenyl)-1,4-diazepane-1-carboxamide hydrochloride | C12H16N3OCl·HCl | 1197685-68-9 | Details |
| tert-Butyl 1H-pyrrol-2-ylcarbamate | C9H14N2O2 | 1784224-90-3 | Details |
| 2-{[4-(4-Methoxyphenyl)-5-(4-methylphenyl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetohydrazide | C18H19N5O2S | 893726-52-8 | Details |
| INPP5K Blocking Peptide | Details |
| Ethyl 4-O-acetyl-3,6-di-O-benzyl-2-deoxy-2-phthalimido-b-D-thioglucopyranoside | C32H33NO7S | 138730-66-2 | Details |
| RTN3 antibody | Details |
| 2-Methyl-4-nitrobenzene-1-sulfonamide | C7H8N2O4S | 22952-19-8 | Details |
| Mouse IL17 ELISA kit | Details |
| 1-[1-(Morpholin-4-yl)cyclopentyl]ethan-1-amine dihydrochloride | C11H24Cl2N2O | 1354957-61-1 | Details |
| 5-Fluorouridine | C9H11FN2O6 | 77180-80-4 | Details |
| GAD65/IA2/Islet Cell Antibody Positive Human Plasma | Details |
| Digalactosyldiacylglycerol - 10mg/ml in Chloroform-Methanol | C51H84O15 | 1531639-03-8 | Details |
| tert-Butyl 2-(1-aminocyclopropyl)piperidine-1-carboxylate | C13H24N2O2 | 1780431-89-1 | Details |
| cyclopropyl[3-(trifluoromethyl)phenyl]methanamine | C11H12F3N | 59382-27-3 | Details |
| 1-(4-Fluorophenyl)-2-methoxyethan-1-amine | C9H12FNO | 321839-91-2 | Details |
| Slc16a3 Blocking Peptide | Details |
| 5-Bromo-1H-pyrrolo[2,3-b]pyridine-3-sulfonyl fluoride | C7H4BrFN2O2S | 2138133-25-0 | Details |
| 7-Fluoro-3-methyl-1λ?-benzothiophene-1,1-dione | C9H7FO2S | 1423034-13-2 | Details |
| [1-(2-Bromophenyl)cyclopropyl]methanol | C10H11BrO | 886366-19-4 | Details |
| 5-[(2,6-Difluorophenyl)methyl]-1,3-thiazol-2-amine hydrochloride | C10H9ClF2N2S | 1955553-92-0 | Details |
| 2-{4-[(tert-Butoxy)carbonyl]piperazin-1-yl}pyrimidine-5-carboxylic acid | C14H20N4O4 | 253315-11-6 | Details |
| tert-Butyl N-[(1R)-2-amino-1-phenylethyl]carbamate | C13H20N2O2 | 137102-65-9 | Details |
| 5-Chloro-3-(3,5-dichlorophenyl)-1,2,4-oxadiazole | C8H3Cl3N2O | 1178078-56-2 | Details |
| 4-Methoxy-3-(2-methylpropoxy)benzaldehyde | C12H16O3 | 57724-26-2 | Details |
| 3-Chloro-4-(chloromethyl)benzonitrile | C8H5Cl2N | 64262-07-3 | Details |
| Poricoic acid G | C30H46O5 | 415724-84-4 | Details |
| Human Serum (FABP free) | Details |
| PE2 antibody | Details |
| 2-[(4-Methylphenyl)methoxy]acetic acid | C10H12O3 | 51934-40-8 | Details |
| 5-(3-Nitrophenyl)thiophene-2-carbaldehyde | C11H7NO3S | 38401-73-9 | Details |
| 3-Chloro-4-(2-methoxyethanesulfonyl)aniline | 1541378-81-7 | Details |
| Product Total： Product Page： | ||||
| 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 | ||||